BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $53,000 | +15.2% | 15,804 | 0.0% | 0.00% | – |
| Q4 2018 | $46,000 | -52.6% | 15,804 | 0.0% | 0.00% | – |
| Q3 2018 | $97,000 | -17.1% | 15,804 | 0.0% | 0.00% | – |
| Q2 2018 | $117,000 | +58.1% | 15,804 | +39.6% | 0.00% | – |
| Q1 2018 | $74,000 | -22.1% | 11,319 | 0.0% | 0.00% | – |
| Q4 2017 | $95,000 | -27.5% | 11,319 | 0.0% | 0.00% | – |
| Q3 2017 | $131,000 | -0.8% | 11,319 | 0.0% | 0.00% | – |
| Q2 2017 | $132,000 | – | 11,319 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| X-Square Capital, LLC | 22,374 | $105,000 | 0.10% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |